期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
邵长荣辨治“喘肿”经验 被引量:1
1
作者 倪伟 张惠勇 吴定中 《上海中医药杂志》 2009年第7期3-4,共2页
阐述邵长荣教授所提出"喘肿"的概念,并分析其病机,提出治疗"喘肿"具体四法:宣肺通阳利水法、温阳化饮利水法、疏肝清肺利水法、健脾纳肾法。
关键词 喘肿 慢性阻塞性肺气 肺心病 名中医经验
下载PDF
邵长荣治疗“喘肿”的经验
2
作者 张颖 施红 《四川中医》 1998年第9期6-7,共2页
关键词 喘肿 邵长荣 中医药疗法
下载PDF
效法仲景治心病——附胸痹、喘肿验案
3
作者 王瑾 《新疆中医药》 1989年第3期49-50,47,共3页
张仲景首创理法方药统一的辨证论治体系,是祖国医学临床医学的奠基人。他对于心病的认识深刻,辨证精详,理法严谨,处方周密,用药灵活,疗效卓著,乃为当代医学所推崇。祖国医学认为,心的生理功能为“主血脉”、“藏神”、“开窍于舌”、“... 张仲景首创理法方药统一的辨证论治体系,是祖国医学临床医学的奠基人。他对于心病的认识深刻,辨证精详,理法严谨,处方周密,用药灵活,疗效卓著,乃为当代医学所推崇。祖国医学认为,心的生理功能为“主血脉”、“藏神”、“开窍于舌”、“其华在面”。笔者通过学习,对仲景心病证论的学术思想,谈谈自己的学习心得。 展开更多
关键词 心病 中医药治疗 辨证论治 胸痹 喘肿 验案
下载PDF
武维屏教授应用桑苏桂苓饮治疗慢性肺原性心脏病经验 被引量:4
4
作者 高伟 秦丽玲 武维屏 《天津中医药》 CAS 2018年第1期4-6,共3页
武维屏教授将慢性肺原性心脏病归纳为三期十候,分为悸、痰、肿、绀4型,并认为阳虚饮停是肿喘型肺心病患者的基本体质,临床以桑苏桂苓饮为基本方辨证加减。感邪而发,重视因势利导,合用麻黄剂,驱邪外出,防止"闭门留寇";无感而作... 武维屏教授将慢性肺原性心脏病归纳为三期十候,分为悸、痰、肿、绀4型,并认为阳虚饮停是肿喘型肺心病患者的基本体质,临床以桑苏桂苓饮为基本方辨证加减。感邪而发,重视因势利导,合用麻黄剂,驱邪外出,防止"闭门留寇";无感而作,强调分辨寒热,合用瓜蒌、半夏,调节阴阳,宣畅气机;症状平稳,肿喘不甚,以五苓散温阳化饮,调理体质;久病及肾,命门火衰,合用附子,以助气化,并继之以阴阳同补之品缓缓图之。武维屏教授在使用桑苏桂苓饮的过程中,重视阴阳平衡,强调气机升降,顾护脾胃功能,药少方精,灵活变化,效如桴鼓。 展开更多
关键词 慢性肺源性心脏病 桑苏桂苓饮 治疗经验 武维屏
下载PDF
THE ASSOCIATION BETWEEN TUMOR NECROSIS FACTORαGENE POLYMORPHISM AND ASTHMA 被引量:1
5
作者 高金明 林耀广 +3 位作者 邱长春 刘怡雯 马毅 刘英 《Chinese Medical Sciences Journal》 CAS CSCD 2003年第4期248-253,共6页
Objective.In this study,we investigated the hypothesis that tumor necrosis factor(TNF)α-308gene polymorphism might be of the genetic predisposition to asthma and asthma phenotypes.Methods.TNFα-308gene polymorphism w... Objective.In this study,we investigated the hypothesis that tumor necrosis factor(TNF)α-308gene polymorphism might be of the genetic predisposition to asthma and asthma phenotypes.Methods.TNFα-308gene polymorphism was genotyped in221random unrelated Northern Chinese population(comprising125asthmatics and96healthy controls)and52individuals from12asthmatic families with Han ethnic by using polymerase chain reaction(PCR)-restriction fragment length polymor-phism(RFLP).Methacholine(Mch)broncho-challenge test,bronchial reversibility test and lung function were underwent in all asthmatics.Results.TNFα-3082homozygosity was present at a significantly higher frequency in asthmatics than that in controls(20.8%vs11.4%,P<0.05,OR2.259),the TNF allele2was also higher in asthmatics compared with controls(0.42vs0.33,P<0.01).TNFα-3082homozygosity was an weak independent risk factor for asthma etiology(OR0.226,P<0.05).Moreover,patients carrying TNFα-3082homozy-gosity had less responsive to inhaledβ 2 -agonist in20minutes than patients carrying other two genotypes(24.1%vs29.5%vs38.8%,P<0.05).Linkage analysis didn’t support that TNFαgene was linked to asthma (Likelihood of odds,LOD<1)based on familial data.Conclusion These results suggest that TNFα-3082homozygosity may be of a component contribut-ing to the genetic predisposition to asthma ,and airway responsiveness toβ2 -agonist. 展开更多
关键词 tumor necrosis factor ASTHMA GENETIC
下载PDF
MEDICINAL VESICULATION THERAPY AND ITS CLINICAL APPLICATION
6
作者 王伟 刘海静 孙占玲 《World Journal of Acupuncture-Moxibustion》 2002年第4期33-36,共4页
In this paper, the authors introduce medicinal vesiculation therapy from its origin, points for attention in clinical application, and their individual experiences. In clinical application, the authors advocate: ① av... In this paper, the authors introduce medicinal vesiculation therapy from its origin, points for attention in clinical application, and their individual experiences. In clinical application, the authors advocate: ① avoid using drugs that are over-irritating in the property, and strictly controlling the dose of drugs and the duration of application, ② in selection of drugs, some factors as patients’ conditions, the season, the geographic location, etc. should be taken into account. In the present paper, 3 typical cases of bronchial asthma, tonsil swelling and facial paralysis treated with medicinal vesiculation therapy are introduced. Clinical practice demonstrates that this therapy is economical, simple and convenient and fairly effective in treatment of some chronic diseases. 展开更多
关键词 Medicinal vesiculation therapy Clinical application
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部